Case Report
Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation
Table 1
An overview of relevant laboratory parameters during the clinical course of the patient.
| Parameters | Reference range | Admission Day 0 | Day 5 | Day 1 of HLH-04 protocol | Day 5 of HLH-04 protocol | Day 10 of HLH-04 protocol | Day 15 of HLH-04 protocol | Day 20 of HLH-04 protocol | Day of discharge |
| Hemoglobin (g/-dL) | 13.0–18.0 | 8.7 | 7.8 | 10.8 | 10.2 | 9.7 | 8.2 | 8.5 | 9.5 | Neutrophils (109xL) | 2.0–7.5 | 0.8 | 0.99 | 0.75 | 0.92 | 1.02 | 0.79 | 0.42 | 3.44 | Lymphocytes (109/L) | 1.5–4.0 | 1.61 | 1.07 | 1.44 | 2.3 | 0.48 | 0.41 | 0.84 | 2.16 | Platelet count (109/L) | 150–450 | 63 | 54 | 41 | 87 | 68 | 69 | 221 | 273 | Ferritin (μg/L) | 11–172 | 1420 | 1912 | 948 | 1821 | 1612 | 976 | 881 | 371 | Fibrinogen (g/L) | 2.0–4.0 | — | 1.5 | 1.6 | 0.9 | 1.2 | 1.4 | 1.6 | 1.9 | Triglyceride (mmol/L) | 0.5–2.20 | 3.13 | — | — | — | — | — | — | — | Direct bilirubin (μmol/L) | 1.7–6.7 | 20 | 80 | — | — | — | — | — | 34 | ALT (IU/L) | 9–24 | 502 | 707 | 611 | 323 | 303 | 257 | 274 | 128 | AST (IU/L) | 14–35 | 354 | 608 | 390 | 189 | 113 | 79 | 89 | 63 | ALP (IU/L) | 59–164 | 994 | 885 | 967 | 631 | 413 | 305 | 309 | 253 | GGT (IU/L) | 7–21 | 250 | 219 | 569 | 424 | 535 | 647 | 782 | 1025 | sIL-2r (U/ml) | 158–623 | — | — | — | 15900 | — | — | — | — |
|
|